Atara Biotherapeutics
ATRA
ATRA
90 hedge funds and large institutions have $612M invested in Atara Biotherapeutics in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
13% more call options, than puts
Call options by funds: $1.46M | Put options by funds: $1.29M
12% less capital invested
Capital invested by funds: $695M → $612M (-$83.3M)
Holders
90
Holding in Top 10
3
Calls
$1.46M
Puts
$1.29M
Top Buyers
| 1 | +$37M | |
| 2 | +$33M | |
| 3 | +$29.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$28.4M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$27.4M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$3.52M | |
| 3 | -$1.95M | |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$1.23M |
| 5 |
JP Morgan Chase
New York
|
-$1.2M |